Skip to main content
Article thumbnail
Location of Repository

Transcription Factor SP4 Is a Susceptibility Gene for Bipolar Disorder

By Xianjin Zhou, Wei Tang, Tiffany A. Greenwood, Shengzhen Guo, Lin He, Mark A. Geyer and John R. Kelsoe


The Sp4 transcription factor plays a critical role for both development and function of mouse hippocampus. Reduced expression of the mouse Sp4 gene results in a variety of behavioral abnormalities relevant to human psychiatric disorders. The human SP4 gene is therefore examined for its association with both bipolar disorder and schizophrenia in European Caucasian and Chinese populations respectively. Out of ten SNPs selected from human SP4 genomic locus, four displayed significant association with bipolar disorder in European Caucasian families (rs12668354, p = 0.022; rs12673091, p = 0.0005; rs3735440, p = 0.019; rs11974306, p = 0.018). To replicate the genetic association, the same set of SNPs was examined in a Chinese bipolar case control sample. Four SNPs displayed significant association (rs40245, p = 0.009; rs12673091, p = 0.002; rs1018954, p = 0.001; rs3735440, p = 0.029), and two of them (rs12673091, rs3735440) were shared with positive SNPs from European Caucasian families. Considering the genetic overlap between bipolar disorder and schizophrenia, we extended our studies in Chinese trios families for schizophrenia. The SNP7 (rs12673091, p = 0.012) also displayed a significant association. The SNP7 (rs12673091) was therefore significantly associated in all three samples, and shared the same susceptibility allele (A) across all three samples. On the other hand, we found a gene dosage effect for mouse Sp4 gene in the modulation of sensorimotor gating, a putative endophenotype for both schizophrenia and bipolar disorder. The deficient sensorimotor gating in Sp4 hypomorphic mice was partially reversed by the administration of dopamine D2 antagonist or mood stabilizers. Both human genetic and mouse pharmacogenetic studies support Sp4 gene as a susceptibility gene for bipolar disorder or schizophrenia. The studies on the role of Sp4 gene in hippocampal development may provide novel insights for the contribution of hippocampal abnormalities in these psychiatric disorders

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2001). A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22.
  2. (1999). A genomic screen of autism: evidence for a multilocus etiology.
  3. (2003). A whole-genome scan in 164 Dutch sib pairs with attention-deficit/ hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q.
  4. (1988). Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.
  5. (2003). Bipolar disorder and schizophrenia: not so distant relatives?
  6. (1986). Carbamazepine and ethanol elicited responses in rodents.
  7. (2008). Convergent functional genomics of genome-wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms.
  8. (2005). CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome.
  9. (2001). De novo partial duplication of chromosome 7p in a male with autistic disorder.
  10. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training.
  11. (2000). Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders.
  12. (2002). Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation.
  13. (2006). Endophenotypes in the genetic analyses of mental disorders.
  14. (2001). Genetics of autism: complex aetiology for a heterogeneous disorder.
  15. (2009). Genewide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk.
  16. (2003). Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24.
  17. (2003). Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23–q24, and suggests the presence of additional loci on 1p and 1q.
  18. (2003). Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22.
  19. (2001). Genomewide survey of panic disorder.
  20. (1997). Genomic survey of bipolar illness in the NIMH genetics initiative pedigrees: a preliminary report.
  21. (2004). Haplotype reconstruction from genotype data using Imperfect Phylogeny.
  22. (2005). Haploview: analysis and visualization of LD and haplotype maps.
  23. (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234–258.
  24. (2007). Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice.
  25. (1997). Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q.
  26. (2008). Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.
  27. (2007). MicroRNA targeting specificity in mammals: determinants beyond seed pairing.
  28. (2002). Mouse genetic models for prepulse inhibition: an early review.
  29. (2007). Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors.
  30. (2005). Parental phenotypes in family-based association analysis.
  31. (2003). Pedigree disequilibrium tests for multilocus haplotypes.
  32. (2004). Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis–a longitudinal study.
  33. (2005). Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization.
  34. (1998). Results of a genome-wide genetic screen for panic disorder.
  35. (2006). Schizophrenia and bipolar disorder: differences and overlaps.
  36. (2001). Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania.
  37. (2007). Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes,
  38. (1996). Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability, and male fertility.
  39. (2006). Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
  40. (2001). Targeting’’ schizophrenia in mice.
  41. (2007). The role of site accessibility in microRNA target recognition.
  42. (1999). The Sp-family of transcription factors.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.